S&P 500   5,015.60 (+0.09%)
DOW   37,961.30 (+0.49%)
QQQ   422.29 (-0.26%)
AAPL   165.90 (-0.68%)
MSFT   404.60 (+0.08%)
META   496.34 (-1.09%)
GOOGL   155.11 (-0.58%)
AMZN   178.55 (-0.37%)
TSLA   149.58 (-0.23%)
NVDA   841.22 (-0.65%)
AMD   153.57 (-0.97%)
NIO   3.88 (-3.00%)
BABA   68.78 (-0.15%)
T   16.36 (+0.18%)
F   12.21 (+1.24%)
MU   110.42 (-1.35%)
GE   153.47 (+0.35%)
CGC   7.98 (+1.92%)
DIS   112.15 (-0.25%)
AMC   2.92 (+0.00%)
PFE   25.49 (+0.39%)
PYPL   62.34 (+0.39%)
XOM   119.54 (+0.86%)
S&P 500   5,015.60 (+0.09%)
DOW   37,961.30 (+0.49%)
QQQ   422.29 (-0.26%)
AAPL   165.90 (-0.68%)
MSFT   404.60 (+0.08%)
META   496.34 (-1.09%)
GOOGL   155.11 (-0.58%)
AMZN   178.55 (-0.37%)
TSLA   149.58 (-0.23%)
NVDA   841.22 (-0.65%)
AMD   153.57 (-0.97%)
NIO   3.88 (-3.00%)
BABA   68.78 (-0.15%)
T   16.36 (+0.18%)
F   12.21 (+1.24%)
MU   110.42 (-1.35%)
GE   153.47 (+0.35%)
CGC   7.98 (+1.92%)
DIS   112.15 (-0.25%)
AMC   2.92 (+0.00%)
PFE   25.49 (+0.39%)
PYPL   62.34 (+0.39%)
XOM   119.54 (+0.86%)
S&P 500   5,015.60 (+0.09%)
DOW   37,961.30 (+0.49%)
QQQ   422.29 (-0.26%)
AAPL   165.90 (-0.68%)
MSFT   404.60 (+0.08%)
META   496.34 (-1.09%)
GOOGL   155.11 (-0.58%)
AMZN   178.55 (-0.37%)
TSLA   149.58 (-0.23%)
NVDA   841.22 (-0.65%)
AMD   153.57 (-0.97%)
NIO   3.88 (-3.00%)
BABA   68.78 (-0.15%)
T   16.36 (+0.18%)
F   12.21 (+1.24%)
MU   110.42 (-1.35%)
GE   153.47 (+0.35%)
CGC   7.98 (+1.92%)
DIS   112.15 (-0.25%)
AMC   2.92 (+0.00%)
PFE   25.49 (+0.39%)
PYPL   62.34 (+0.39%)
XOM   119.54 (+0.86%)
S&P 500   5,015.60 (+0.09%)
DOW   37,961.30 (+0.49%)
QQQ   422.29 (-0.26%)
AAPL   165.90 (-0.68%)
MSFT   404.60 (+0.08%)
META   496.34 (-1.09%)
GOOGL   155.11 (-0.58%)
AMZN   178.55 (-0.37%)
TSLA   149.58 (-0.23%)
NVDA   841.22 (-0.65%)
AMD   153.57 (-0.97%)
NIO   3.88 (-3.00%)
BABA   68.78 (-0.15%)
T   16.36 (+0.18%)
F   12.21 (+1.24%)
MU   110.42 (-1.35%)
GE   153.47 (+0.35%)
CGC   7.98 (+1.92%)
DIS   112.15 (-0.25%)
AMC   2.92 (+0.00%)
PFE   25.49 (+0.39%)
PYPL   62.34 (+0.39%)
XOM   119.54 (+0.86%)

Biogen (BIIB) SEC Filings & 10K Form

$190.72
+0.20 (+0.10%)
(As of 09:46 AM ET)

Recent Biogen SEC Filings

DateFilerForm TypeView
04/12/2024
4:01 PM
Biogen (Filer)
Form PRE 14A
04/03/2024
7:24 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:11 PM
Biogen (Issuer)
Murphy Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
9:08 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
6:54 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
9:12 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
8:31 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:33 PM
Biogen (Issuer)
Izzar Rachid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:36 PM
Biogen (Issuer)
Gregory Ginger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:39 PM
ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:27 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:28 PM
Biogen (Issuer)
Murphy Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:29 PM
Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
9:24 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
8:13 PM
Biogen (Issuer)
Rowinsky Eric K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
4:56 PM
ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:00 PM
Biogen (Issuer)
Izzar Rachid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:01 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:03 PM
Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:04 PM
Biogen (Issuer)
Murphy Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:06 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:14 PM
Biogen (Issuer)
Gregory Ginger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
6:07 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
6:07 PM
Biogen (Filed by)
Denali Therapeutics Inc. (Subject)
Form SC 13G/A
02/12/2024
6:11 PM
Biogen (Filed by)
SANGAMO THERAPEUTICS, INC (Subject)
Form SC 13G/A
02/12/2024
10:21 AM
Biogen (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/12/2024
10:10 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
9:50 AM
Biogen (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/09/2024
7:11 PM
Biogen (Issuer)
Izzar Rachid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:12 PM
Biogen (Issuer)
Grogan Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:14 PM
Biogen (Issuer)
Gregory Ginger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:16 PM
ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
6:56 PM
Biogen (Issuer)
Viehbacher Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
6:59 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:01 PM
Biogen (Issuer)
Murphy Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:03 PM
Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:06 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:08 PM
Biogen (Issuer)
Keeney Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:38 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
9:44 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2024
4:34 PM
Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
New crypto project uncovers 2,050% in 65 days (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.
01/31/2024
4:35 PM
Biogen (Issuer)
Murphy Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:36 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:27 PM
ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:30 PM
Biogen (Issuer)
Gregory Ginger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:31 PM
Biogen (Issuer)
Izzar Rachid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:33 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
4:52 PM
Biogen (Issuer)
Patolawala Monish D (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/12/2023
4:02 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
3:36 PM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2023
9:06 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2023
6:02 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2023
4:15 PM
Biogen (Issuer)
Grogan Jane (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/28/2023
4:25 PM
Biogen (Filer)
Form 8-K/A
09/28/2023
4:30 PM
Biogen (Reporting)
Biogen MA Inc. (Reporting)
SANGAMO THERAPEUTICS, INC (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2023
3:38 PM
Biogen (Filed by)
REATA PHARMACEUTICALS INC (Subject)
Form SC 13D/A
09/26/2023
4:25 PM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2023
5:06 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
5:08 PM
Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
10:23 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/01/2023
3:36 PM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2023
6:00 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2023
6:02 AM
Biogen (Filer)
Form DEFA14A
07/28/2023
6:11 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2023
6:13 AM
Biogen (Filer)
Form DEFA14A
07/25/2023
6:03 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2023
4:33 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:35 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:37 PM
Biogen (Issuer)
Izzar Rachid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
2:37 PM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2023
3:24 PM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2023
6:00 PM
Biogen (Issuer)
Freire Maria C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
6:01 PM
Biogen (Issuer)
HAWKINS WILLIAM A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
6:03 PM
Biogen (Issuer)
LANGER SUSAN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/28/2023
6:04 PM
Biogen (Issuer)
LANGER SUSAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
6:05 PM
Biogen (Issuer)
Mantas Jesus B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
6:06 PM
Biogen (Issuer)
Rowinsky Eric K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
6:10 PM
Biogen (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
5:59 PM
Biogen (Issuer)
DORSA CAROLINE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
6:25 AM
Biogen (Filer)
Form DEFR14A
06/13/2023
6:28 AM
Biogen (Filer)
Form DEFA14A
05/03/2023
8:02 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2023
7:05 PM
Biogen (Issuer)
Gregory Ginger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
7:08 PM
Biogen (Issuer)
Keeney Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2023
4:23 PM
Biogen (Filer)
Form DEFA14A
04/28/2023
4:17 PM
Biogen (Filer)
Form ARS
04/28/2023
12:07 PM
Biogen (Subject)
Gregory Ginger (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/25/2023
3:45 PM
Biogen (Issuer)
Keeney Adam (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/25/2023
3:21 PM
Biogen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2023
3:21 PM
Biogen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2023
6:02 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
New crypto project uncovers 2,050% in 65 days (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:BIIB) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners